Bavarian Nordic boosts 2025 guidance as takeover offer looms
Bavarian Nordic reported a strong H1 2025 as the company prepares to receive an offer letter.
Business & Regulation
CSL slashes 15% of workforce and offshoots vaccine division
Eli Lilly accused of bribing providers to prescribe GLP-1RA drugs
Podcast: US tariff news and Q2 earnings influence pharma trends
Mounjaro and Zepbound fuel strong Q2 growth for Eli Lilly
Why Liverpool’s Wirtz is causing concern at big pharma company Bayer
Pfizer shares rise 3% after upping profit forecast for 2025
Pharma CEOs downplay impact of tariffs amid rising cost concerns
